Biological disease-modifying anti-rheumatic drugs are equally effective in psoriatic arthritis patients with low and high joint counts.

Möller, Burkhard; Scholz, Godehard A; Amsler, Jennifer; Ciurea, Adrian; Micheroli, Raphael; Nissen, Michael J; Papagiannoulis, Eleftherios; Blapp, Christoph; Scherer, Almut; Yawalkar, Nikhil.

Afiliação

Möller B; Department of Rheumatology and Immunology, Inselspital, University Hospital of Berne, Berne, Switzerland.
Scholz GA; Department of Rheumatology and Immunology, Inselspital, University Hospital of Berne, Berne, Switzerland.
Amsler J; Department of Rheumatology and Immunology, Inselspital, University Hospital of Berne, Berne, Switzerland.
Ciurea A; Department of Rheumatology, University Hospital of Zurich, Zurich, Switzerland.
Micheroli R; Department of Rheumatology, University Hospital of Zurich, Zurich, Switzerland.
Nissen MJ; Department of Rheumatology, University Hospital of Geneva, Geneva, Switzerland.
Papagiannoulis E; Swiss Clinical Quality Management (SCQM) Foundation, Zurich, Switzerland.
Blapp C; Swiss Clinical Quality Management (SCQM) Foundation, Zurich, Switzerland.
Scherer A; Swiss Clinical Quality Management (SCQM) Foundation, Zurich, Switzerland.
Yawalkar N; Department of Dermatology, Inselspital, University Hospital of Berne, Berne, Switzerland.